ZEN-3694 is under clinical development by Zenith Epigenetics and currently in Phase I for Melanoma. According to GlobalData, Phase I drugs for Melanoma have a 75% phase transition success rate (PTSR) ...
Hosted on MSN5mon
AMD Commits to AM5 Support through 2027+ as Company Confirms Zen 6 and Zen 7 ArchitecturesSource Join the discussion in our forums... The post AMD Commits to AM5 Support through 2027+ as Company Confirms Zen 6 and Zen 7 Architectures appeared first on The FPS Review.
Ashok Atluri, Chairman and Managing Director of Zen Technologies, aims to maintain its guidance of 35% EBITDA margins over the next three years.
06-May-24 06-Sep-24 06-Sep-24 1 Rs.1.0000 per share(100%)Final Dividend 08-May-23-08-Sep-23 0.2 Rs.0.2000 per share(20%)Final Dividend 09-May-22 22-Sep-22 21-Sep-22 0.1 Rs.0.1000 per share(10% ...
Defense training and anti-drone solutions provider Zen Technologies has signed up with US-based AVT Simulation in a 'strategic push' into American market, sending shares higher by close to 3% in ...
However, we await further details on this partnership between Zen Tech and AVT Simulation to gauge the opportunity size," Nuvama added. On Thursday, the company said, "The company has formalized ...
Shares of Zen Technologies Ltd have delivered multibagger returns in the long term. The defence sector stock has risen 958% in two years and gained 3,659% in five years. The stock which closed at ...
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment.?It is focused on commercializing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback